Holen Sie sich die Stockscreener-App
3.2638
1.36%
-0.0462
Schlusskurs vom Vortag:
$3.31
Offen:
$3.27
24-Stunden-Volumen:
1.88M
Relative Volume:
0.40
Marktkapitalisierung:
$321.37M
Einnahmen:
$775.09M
Nettoeinkommen (Verlust:
$-58.68M
KGV:
-24.61
EPS:
-0.1326
Netto-Cashflow:
$64.06M
1W Leistung:
-10.79%
1M Leistung:
-27.92%
6M Leistung:
-30.24%
1J Leistung:
-44.38%
1-Tages-Spanne:
$3.21
$3.3299
1-Wochen-Bereich:
$3.21
$3.6987
52-Wochen-Spanne:
$3.21
$6.28
Goodrx Holdings Inc Stock (GDRX) Company Profile
Firmenname
Goodrx Holdings Inc
Sektor
Branche
Telefon
(855) 268-2822
Adresse
2701 OLYMPIC BOULEVARD, SANTA MONICA
Vergleichen Sie GDRX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GDRX
Goodrx Holdings Inc
|
3.26 | 1.15B | 775.09M | -58.68M | 64.06M | -0.1326 |
|
VEEV
Veeva Systems Inc
|
292.29 | 47.98B | 2.97B | 809.93M | 1.33B | 4.8743 |
|
TEM
Tempus Ai Inc
|
86.30 | 15.41B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
66.31 | 12.54B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
95.14 | 8.17B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
37.16 | 7.08B | 906.14M | -52.62M | 89.62M | -0.3621 |
Goodrx Holdings Inc Stock (GDRX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-11 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2024-12-04 | Eingeleitet | Mizuho | Neutral |
| 2024-08-09 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2024-05-23 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-05-16 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2024-04-10 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2024-03-25 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-03-01 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2024-02-26 | Eingeleitet | Leerink Partners | Outperform |
| 2024-01-02 | Herabstufung | BofA Securities | Buy → Underperform |
| 2023-08-10 | Hochstufung | DA Davidson | Neutral → Buy |
| 2023-07-31 | Hochstufung | TD Cowen | Market Perform → Outperform |
| 2022-12-01 | Eingeleitet | Citigroup | Buy |
| 2022-11-04 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2022-09-16 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2022-09-07 | Eingeleitet | Truist | Hold |
| 2022-08-12 | Eingeleitet | DA Davidson | Neutral |
| 2022-06-10 | Herabstufung | Goldman | Buy → Neutral |
| 2022-06-06 | Fortgesetzt | BofA Securities | Buy |
| 2022-06-01 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2022-05-10 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2022-05-10 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-05-10 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2022-05-10 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2022-04-11 | Eingeleitet | Wells Fargo | Equal Weight |
| 2022-04-07 | Eingeleitet | Guggenheim | Buy |
| 2022-04-01 | Fortgesetzt | Credit Suisse | Neutral |
| 2022-03-15 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2022-03-01 | Bestätigt | Barclays | Overweight |
| 2022-03-01 | Bestätigt | BofA Securities | Neutral |
| 2022-03-01 | Herabstufung | Cowen | Outperform → Market Perform |
| 2022-03-01 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2022-03-01 | Bestätigt | Evercore ISI | Outperform |
| 2022-03-01 | Bestätigt | Goldman | Buy |
| 2022-03-01 | Bestätigt | JP Morgan | Underweight |
| 2022-03-01 | Bestätigt | RBC Capital Mkts | Outperform |
| 2022-03-01 | Bestätigt | SVB Leerink | Outperform |
| 2022-01-07 | Eingeleitet | Goldman | Buy |
| 2021-12-21 | Eingeleitet | Stephens | Overweight |
| 2021-12-02 | Eingeleitet | Jefferies | Buy |
| 2021-08-31 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2021-08-13 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2021-05-28 | Eingeleitet | Robert W. Baird | Neutral |
| 2021-04-06 | Fortgesetzt | Evercore ISI | Outperform |
| 2021-01-25 | Eingeleitet | Guggenheim | Buy |
| 2020-11-19 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-11-18 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2020-10-19 | Eingeleitet | Barclays | Equal Weight |
| 2020-10-19 | Eingeleitet | BofA Securities | Neutral |
| 2020-10-19 | Eingeleitet | Citigroup | Buy |
| 2020-10-19 | Eingeleitet | Cowen | Outperform |
| 2020-10-19 | Eingeleitet | Credit Suisse | Outperform |
| 2020-10-19 | Eingeleitet | Deutsche Bank | Hold |
| 2020-10-19 | Eingeleitet | Goldman | Neutral |
| 2020-10-19 | Eingeleitet | JP Morgan | Neutral |
| 2020-10-19 | Eingeleitet | Morgan Stanley | Overweight |
| 2020-10-19 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2020-10-19 | Eingeleitet | SVB Leerink | Outperform |
| 2020-10-19 | Eingeleitet | UBS | Buy |
Alle ansehen
Goodrx Holdings Inc Aktie (GDRX) Neueste Nachrichten
Goodrx stock hits 52-week low at 3.3 USD By Investing.com - Investing.com Australia
GoodRx Holdings Inc (GDRX) Q3 2025 Earnings Report Preview: What To Look For - Yahoo Finance
Ranking GoodRx Holdings Inc. among high performing stocks via tools2025 Price Action Summary & Weekly Consistent Profit Watchlists - newser.com
Using Ichimoku Cloud for GoodRx Holdings Inc. technicals2025 Top Gainers & Community Verified Swing Trade Signals - newser.com
Quantitative breakdown of GoodRx Holdings Inc. recent movePortfolio Gains Report & Reliable Breakout Stock Forecasts - newser.com
Can GoodRx Holdings Inc. stock double in next 5 yearsEarnings Beat & AI Enhanced Trading Alerts - newser.com
GoodRx Holdings Co-Chairman Trevor Bezdek Steps Down - TipRanks
GoodRx Holdings Announces Management Change - TradingView
Goodrx stock hits 52-week low at 3.3 USD - Investing.com
GoodRx Holdings Inc (GDRX) Q3 2025: Everything You Need To Know Ahead Of Earnings - Yahoo Finance
Is GoodRx Holdings Inc. still worth holding after the dipJuly 2025 Final Week & Daily Profit Focused Stock Screening - newser.com
Custom watchlist performance reports with GoodRx Holdings Inc.Rate Hike & High Return Stock Watch Alerts - newser.com
Does GoodRx Holdings Inc. fit your quant trading model2025 Risk Factors & Expert Curated Trade Setups - newser.com
How strong is GoodRx Holdings Inc. stock revenue growthRate Cut & Expert Curated Trade Setup Alerts - newser.com
Smart tools for monitoring GoodRx Holdings Inc.’s price actionMarket Sentiment Report & Growth Focused Stock Reports - newser.com
Risk adjusted return profile for GoodRx Holdings Inc. analyzed2025 Geopolitical Influence & Consistent Profit Trade Alerts - newser.com
Measuring GoodRx Holdings Inc.’s beta against major indicesPortfolio Return Summary & Safe Entry Zone Identification - newser.com
Real time breakdown of GoodRx Holdings Inc. stock performanceGDP Growth & Weekly Market Pulse Updates - newser.com
Reversal indicators forming on GoodRx Holdings Inc. stockJuly 2025 Intraday Action & Growth Focused Entry Point Reports - newser.com
Is GoodRx Holdings Inc. meeting your algorithmic filter criteriaWeekly Stock Summary & Short-Term Trading Opportunity Alerts - newser.com
Detecting price anomalies in GoodRx Holdings Inc. with AIPortfolio Return Report & Free Expert Approved Momentum Trade Ideas - newser.com
Does GoodRx Holdings Inc. qualify in momentum factor screeningBond Market & Community Shared Stock Ideas - newser.com
GoodRx (GDRX) Q3 Earnings Report Preview: What To Look For - Barchart.com
Real time social sentiment graph for GoodRx Holdings Inc.Earnings Growth Summary & AI Driven Stock Movement Reports - newser.com
Investors Don't See Light At End Of GoodRx Holdings, Inc.'s (NASDAQ:GDRX) Tunnel And Push Stock Down 33% - simplywall.st
Institutional scanner results for GoodRx Holdings Inc.July 2025 Levels & Real-Time Chart Breakout Alerts - newser.com
Q3 2025 Earnings Call - MarketScreener
GoodRx Holdings, Inc. (GDRX) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
Finanzdaten der Goodrx Holdings Inc-Aktie (GDRX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.17%
0.34%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):